Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon - Wikidata - awgldk - TriplyDB

Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon

Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon

http://www.wikidata.org/entity/Q34336505

about

Hepatocellular Carcinoma 11 and a Half Years after the Resolution of Chronic Hepatitis C Virus Infection Successfully Treated with Interferon

http://www.wikidata.org/entity/Q34336505

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@ast

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@en

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@nl

type

label

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@ast

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@en

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@nl

prefLabel

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@ast

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@en

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@nl

P1433

Q34336505-E348C2E0-CADB-4B54-8E12-236964E38471

P1476

Q34336505-D5FBA131-3E95-4ECC-9209-6938FEFAA56A

P2093

Q34336505-2188A3A1-EA97-4A39-8363-8B7449640F5B

Q34336505-5B14B188-F3F2-4F9D-9D2D-3291B59CB20D

Q34336505-619F13B6-62BB-4B39-AF1B-22D34E772CFC

Q34336505-831A4FCA-CDAA-49E6-A3B5-AC4A80F9D017

Q34336505-935BC95B-DEEF-481C-B924-2361D5DE9FBD

Q34336505-9F9E32AC-6A5F-43E8-A606-8D664C428F20

Q34336505-BD02CB04-0994-403D-AC7C-2209AD4D5202

Q34336505-C94CF79E-AAA5-4E2C-87CD-9ED1D4805087

P2860

Q34336505-54119536-4C85-4708-8C4E-CBE900A0225C

Q34336505-66CE530E-1C98-48F9-9E92-C9E9882399BF

Q34336505-7DF30D97-8ED2-4E87-BC4C-4F1DF2DB30D3

Q34336505-8D08138D-42DB-435D-8D40-BDBCBBA60502

Q34336505-915B9086-AABA-430C-A11F-52C19099F6BD

Q34336505-971AF18C-5FC8-4698-BD30-38DCE8C11CC7

Q34336505-CCC3B6F5-3714-46B8-906F-5120E11C2CB8

Q34336505-D61A6197-7101-409F-81FB-8E91F8FA5C98

P304

Q34336505-579ED642-B24E-4657-BC08-9DEB3C4BA79A

P31

Q34336505-18fdffab-372f-4775-a3bf-a427066f338e

Q34336505-2042DA07-4169-4A8F-99A4-E6932AA3B36D

P356

Q34336505-BB8129C4-194D-4F80-9AC4-A54FD7BC9463

P433

Q34336505-9718D011-8B57-4818-85F6-B3ED65093479

P478

Q34336505-22412AE9-69E5-4ABB-9C39-3F270A72A81E

P577

Q34336505-090F17B7-8CD6-4D4E-86D4-D819A068F8FE

P5875

Q34336505-69E55E5F-D8F5-4CB0-807A-92B9888F3CCD

P698

Q34336505-A3FB6153-B39B-4A98-AC2D-C613F7DD32AC

P932

Q34336505-082A40D9-3154-42ED-AB74-91DF40621FE7

P356

P1433

Case reports in gastroenterology

P1476

Hepatocellular Carcinoma 11 an ...... sfully Treated with Interferon

@en

P2093

Akihiko Okumura

http://www.w3.org/2001/XMLSchema#string

Ken Sato

http://www.w3.org/2001/XMLSchema#string

Minoru Ayada

http://www.w3.org/2001/XMLSchema#string

Naoki Hotta

http://www.w3.org/2001/XMLSchema#string

Shinichi Kakumu

http://www.w3.org/2001/XMLSchema#string

Tetsuya Ishikawa

http://www.w3.org/2001/XMLSchema#string

Tomohiko Oohashi

http://www.w3.org/2001/XMLSchema#string

Yasutaka Hijikata

http://www.w3.org/2001/XMLSchema#string

P2860

Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference.

Delayed development of hepatocellular carcinoma during long-term follow-up after eradication of hepatitis C virus by interferon therapy.

Classification of chronic hepatitis: diagnosis, grading and staging.

Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.

Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C. Osaka Liver Disease Study Group.

Characteristic difference of hepatocellular carcinoma between hepatitis B- and C- viral infection in Japan.

Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

Effect of interferon therapy on hepatocellular carcinogenesis in patients with chronic hepatitis type C: A long-term observation study of 1,643 patients using statistical bias correction with proportional hazard analysis.

P304

175-181

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1159/000225244

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

3

http://www.w3.org/2001/XMLSchema#string

P577

2009-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49631798

http://www.w3.org/2001/XMLSchema#string

P698

21103271

http://www.w3.org/2001/XMLSchema#string

P932

2988953

http://www.w3.org/2001/XMLSchema#string